Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT
- 1 January 1997
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- InstrumentationMovement Disorders, 1994
- SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1993
- High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brainSynapse, 1992
- [125I]RTI-55: a potent ligand for dopamine transportersEuropean Journal of Pharmacology, 1991
- Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyAnnals of Neurology, 1990
- Age‐related changes in the human nigrostriatal dopaminergic systemAnnals of Neurology, 1990
- The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studiesMovement Disorders, 1990
- In vivoevaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomographyActa Neurologica Scandinavica, 1987
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973